Latest Research And Development News

Biotron Limited has advanced its Hepatitis B antiviral program while preparing to acquire Sedarex Limited, backed by a $2.5 million capital raise. The move signals a strategic expansion into safer anaesthetics alongside ongoing R&D progress.

Norwood Systems reports a second consecutive quarter of positive operating cash flow, enabling debt reduction and progress in key projects with Optus and Microsoft. The company also secured multiple industry awards, underscoring its innovation momentum.

Altech Batteries has launched immediate sales of sodium nickel chloride batteries through a strategic collaboration with AMPower, while advancing its flagship CERENERGY project in Germany with strong funding and prototype milestones.

CONNEQT Health reported a $2.6 million operating cash outflow in the September quarter but secured $2 million through a convertible note, while expecting a $1.6 million R&D tax refund to shore up liquidity.

BluGlass Limited reports a robust project pipeline exceeding US$100 million, bolstered by initial orders from Collins Aerospace and Infleqtion Inc, alongside strategic board appointments and a $6 million R&D tax rebate.

Sparc Technologies has completed construction of a pioneering green hydrogen pilot plant and secured new patents, while its graphene additive trials show promising corrosion resistance results.

Noxopharm Limited reports growing interest in its Sofra technology with new research collaborations and a safe, well-tolerated HERACLES trial of SOF-SKN. The company also secures funding extensions to support ongoing development.

Fluence Corporation reported a robust 72.9% revenue increase year-to-date Q3 2025, fueled by the Ivory Coast Addendum project, while maintaining its full-year guidance despite some margin pressures.

Green360 Technologies reports strong cash reserves and breakthrough production milestones in low-carbon cement, alongside strategic board appointments and a CEO transition.

Aeeris Ltd reported a profitable quarter with 13% revenue growth and launched its proprietary AWARE system, while navigating the departure of its founder and CEO.

icetana Limited reports its strongest quarterly growth yet, driven by a strategic partnership with SoftBank Robotics that has propelled annual recurring revenue to $2.3 million.

icetana Limited posted a net operating cash outflow of AUD 1.126 million for the quarter ending September 2025, ending with a cash balance of AUD 2.71 million. The company’s cash runway currently covers approximately one quarter based on existing cash flows.